ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,587.68
0.28%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Cara Therapeutics Inc (CARA)

  7. Cara Therapeutics Inc (CARA) 뉴스

CARA Cara Therapeutics Inc

0.6843
-0.0157 (-2.24%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Cara Therapeutics Inc CARA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0157 -2.24% 0.6843 13:00:13
개장가 저가 고가 종가 전일 종가
0.69 0.68 0.7264 0.6843 0.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/04/202420:00GLOBECara Therapeutics to Present at the 23rd Annual Needham..
07/03/202421:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
07/03/202406:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:10EDGAR2Form 8-K - Current report
05/03/202406:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
14/02/202408:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202407:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
06/02/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:59EDGAR2Form 8-K - Current report
30/01/202405:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/01/202406:19EDGAR2Form 8-K - Current report
22/01/202421:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
18/12/202321:10EDGAR2Form 8-K - Current report
18/12/202321:00GLOBECara Therapeutics Announces Outcome from Dose-Finding Part A..
14/11/202306:28EDGAR2Form 8-K - Current report
14/11/202306:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:11EDGAR2Form 8-K - Current report
14/11/202306:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
04/11/202305:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202320:10EDGAR2Form 8-K - Current report
02/11/202320:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
23/10/202320:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
25/09/202320:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
05/09/202320:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
08/08/202305:24EDGAR2Form 8-K - Current report
08/08/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:10EDGAR2Form 8-K - Current report
08/08/202305:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
05/08/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/08/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/08/202320:06EDGAR2Form 8-K - Current report
03/08/202320:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
02/08/202320:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
26/07/202305:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/07/202320:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
03/06/202307:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
01/06/202320:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
18/05/202315:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
16/05/202305:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

NASDAQ
CARA
Cara Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유